A&O Shearman advised Mubadala Capital in closing its acquisition of Fortress Investment Group with Fortress Management. Mubadala Investment Company PJSC completed the acquisition, through its wholly...
Mubadala Capital’s Acquisition of a 90.01% Stake in Fortress from SoftBank
Genmab’s $1.8 Billion Acquisition of ProfoundBio
Cooley, Travers Thorp Alberga and Jun He Law Offices advised ProfoundBio and Wilson Sonsini Goodrich and Rosati advised ProfoundBio on patent matters related to the transaction,...
Boston Scientific’s $3.7 Billion Acquisition of Axonics
Shearman & Sterling represented Boston Scientific Corporation in the transaction, and K&L Gates represented Axonics, Inc. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a definitive...
Fortress Management and Mubadala Capital’s Acquisition of Fortress Investment Group
Kirkland & Ellis and Skadden represented Fortress Investment Group. Shearman & Sterling represented Mubadala Investment Company PJSC, through Mubadala Capital. Morrison & Foerster advised SoftBank Group...
Boston Scientific’s Acquisition of Apollo Endosurgery
Cooley LLP advised Apollo Endosurgery on the deal, while Shearman & Sterling advised Boston Scientific Corporation. Apollo Endosurgery, a medical device company, signed the agreement to be...
Boston Scientific’s $1.75 Billion Acquisition of Baylis Medical Company
Shearman & Sterling advised Boston Scientific Corporation on the acquisition of Baylis Medical Company, assisted by BCF Business Law, in collaboration with Cooley LLP (U.S. lead...
Ardagh Metal Packaging’s Combination with Gores Holdings V
Shearman & Sterling and Elvinger Hoss Prussen advised Ardagh Group S.A. on the deal. Loyens & Loeff advised The Gores Group. Weil advised Gores Holdings V....